Human-Induced Pluripotent Stem Cell Model of Trastuzumab-Induced Cardiac Dysfunction in Patients With Breast Cancer-Reference-Cited by-同舟云学术

Human-Induced Pluripotent Stem Cell Model of Trastuzumab-Induced Cardiac Dysfunction in Patients With Breast Cancer

Published:2019-05-21 Issue:21 Volume:139 Page:2451-2465
ISSN:0009-7322
Container-title:Circulation
language:en
Short-container-title:Circulation

Author:

Kitani Tomoya¹²³,Ong Sang-Ging⁴,Lam Chi Keung¹²³,Rhee June-Wha¹²³,Zhang Joe Z.¹²³,Oikonomopoulos Angelos¹²³,Ma Ning¹²³,Tian Lei¹²³,Lee Jaecheol⁵,Telli Melinda L.⁶,Witteles Ronald M.¹³,Sharma Arun⁷,Sayed Nazish¹²³,Wu Joseph C.¹²⁸³

Affiliation:

1. Stanford Cardiovascular Institute, CA (T.K., C.K.L., J.-W.R., J.Z.Z., A.O., N.M., L.T., R.M.W., N.S., J.C.W.).

2. Institute for Stem Cell Biology and Regenerative Medicine, Stanford, CA (T.K., C.K.L., J.-W.R., J.Z.Z., A.O., N.M., L.T., N.S., J.C.W.).

3. Department of Medicine, Division of Cardiology (T.K., C.K.L., J.-W.R., J.Z.Z., A.O., N.M., L.T., R.M.W., N.S., J.C.W.), Stanford University School of Medicine, CA.

4. Departments of Pharmacology and Medicine, University of Illinois College of Medicine, Chicago (S.-G.P).

5. School of Pharmacy, Sungkyunkwan University, Suwon, Korea (J.L.).

6. Division of Oncology (M.L.T.), Stanford University School of Medicine, CA.

7. Department of Genetics, Harvard Medical School, Boston, MA (A.S.).

8. Stanford Cancer Institute, CA (J.C.W.).

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Physiology (medical),Cardiology and Cardiovascular Medicine

Reference50 articles.

1. Cardiotoxicity of anticancer treatments

2. Cardio-Oncology

3. Cardiovascular Complications of Cancer Therapy

4. Cancer therapy-induced cardiomyopathy: can human induced pluripotent stem cell modelling help prevent it? [published online January 25, 2018];Stack JP;Eur Heart J

5. Personalized medicine in cardio-oncology: the role of induced pluripotent stem cell

Cited by 147 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Inorganic sulfides prevent osimertinib-induced mitochondrial dysfunction in human iPS cell-derived cardiomyocytes;Journal of Pharmacological Sciences;2024-10

2. Clinical trials in-a-dish for cardiovascular medicine;European Heart Journal;2024-09-13

3. Human induced pluripotent stem cell-derived cardiomyocytes (iPSC-CMs) for modeling cardiac arrhythmias: strengths, challenges and potential solutions;Frontiers in Physiology;2024-09-12

4. Underlying mechanisms and management strategies for regorafenib-induced toxicity in hepatocellular carcinoma;Expert Opinion on Drug Metabolism & Toxicology;2024-09-03

5. Cancer and Heart Failure: Dangerous Liaisons;Journal of Cardiovascular Development and Disease;2024-08-27